Illinois HB3686 amends the Controlled Substances Act to classify compounds containing gonadotropin-releasing hormone analogs as Schedule V controlled.

Illinois HB3686 amends the Illinois Controlled Substances Act by adding compounds containing gonadotropin-releasing hormone analogs to Schedule V. This change means these compounds are now regulated under the state's controlled substances laws, affecting how they are prescribed, distributed, and monitored. The bill specifies the inclusion of these compounds in the Schedule V category, aligning them with other substances that have lower potential for abuse and accepted medical uses.

Illinois HB3686 amends the Controlled Substances Act to classify compounds containing gonadotropin-releasing hormone analogs as Schedule V controlled.

Illinois HB3686 amends the Illinois Controlled Substances Act by adding compounds containing gonadotropin-releasing hormone analogs to Schedule V. This change means these compounds are now regulated under the state's controlled substances laws, affecting how they are prescribed, distributed, and monitored. The bill specifies the inclusion of these compounds in the Schedule V category, aligning them with other substances that have lower potential for abuse and accepted medical uses.